Nyumbani › Ugonjwa wa Graft dhidi ya Mwenyeji › Florida
Majaribio ya kliniki ya Ugonjwa wa Graft dhidi ya Mwenyeji katika jimbo la Florida
Masomo 7 ya Ugonjwa wa Graft dhidi ya Mwenyeji yanatafuta washiriki katika vituo vya jimbo la Florida.
Miji katika jimbo la Florida
Maandishi rasmi ya utafiti (Kiingereza)
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- University of Miami, Miami
InaajiriHatua 1/2
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT05531786Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
- University of Miami Sylvester Comprehensive Cancer Center, Miami
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06910969Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
- Moffitt Cancer Center, Tampa
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Ago 2026 · NCT06450925Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Moffitt Cancer Center, Tampa
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Jul 2026 · NCT07216443A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Miami, Miami
InaajiriHatua 2
Umri 2 na zaidi · Jinsia zote · Imesasishwa 16 Jun 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Miami, Miami
- Moffitt Cancer Center, Tampa
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Mei 2026 · NCT06615050A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- AdventHealth Orlando, Orlando
- Moffitt Cancer Center, Tampa
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Des 2025 · NCT06619561Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.